167 related articles for article (PubMed ID: 15577296)
1. Prostate cancer incidence and survival in relation to education (United States).
Steenland K; Rodriguez C; Mondul A; Calle EE; Thun M
Cancer Causes Control; 2004 Nov; 15(9):939-45. PubMed ID: 15577296
[TBL] [Abstract][Full Text] [Related]
2. Calcium, dairy products, and risk of prostate cancer in a prospective cohort of United States men.
Rodriguez C; McCullough ML; Mondul AM; Jacobs EJ; Fakhrabadi-Shokoohi D; Giovannucci EL; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):597-603. PubMed ID: 12869397
[TBL] [Abstract][Full Text] [Related]
3. Screening for prostate cancer: updated experience from the Tyrol study.
Horninger W; Berger A; Pelzer A; Klocker H; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P; Bartsch G
Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158
[TBL] [Abstract][Full Text] [Related]
4. Prostate carcinoma detection and increased prostate-specific antigen levels after 4 years in Dutch and Japanese males who had no evidence of disease at initial screening.
Ito K; Raaijmakers R; Roobol M; Wildhagen M; Yamanaka H; Schröder FH
Cancer; 2005 Jan; 103(2):242-50. PubMed ID: 15578715
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
[TBL] [Abstract][Full Text] [Related]
6. A prospective study of cruciferous vegetables and prostate cancer.
Giovannucci E; Rimm EB; Liu Y; Stampfer MJ; Willett WC
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1403-9. PubMed ID: 14693729
[TBL] [Abstract][Full Text] [Related]
7. Predictors of prostate cancer screening among health fair participants.
Chiu BC; Anderson JR; Corbin D
Public Health; 2005 Aug; 119(8):686-93. PubMed ID: 15949522
[TBL] [Abstract][Full Text] [Related]
8. Diabetes and risk of prostate cancer in a prospective cohort of US men.
Rodriguez C; Patel AV; Mondul AM; Jacobs EJ; Thun MJ; Calle EE
Am J Epidemiol; 2005 Jan; 161(2):147-52. PubMed ID: 15632264
[TBL] [Abstract][Full Text] [Related]
9. Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States.
Rodriguez C; Patel AV; Calle EE; Jacobs EJ; Chao A; Thun MJ
Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):345-53. PubMed ID: 11319175
[TBL] [Abstract][Full Text] [Related]
10. Socio-economic and lifestyle factors associated with the risk of prostate cancer.
Lund Nilsen TI; Johnsen R; Vatten LJ
Br J Cancer; 2000 Apr; 82(7):1358-63. PubMed ID: 10755415
[TBL] [Abstract][Full Text] [Related]
11. Vitamin E supplements and risk of prostate cancer in U.S. men.
Rodriguez C; Jacobs EJ; Mondul AM; Calle EE; McCullough ML; Thun MJ
Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):378-82. PubMed ID: 15006912
[TBL] [Abstract][Full Text] [Related]
12. Is additional testing necessary in men with prostate-specific antigen levels of 1.0 ng/mL or less in a population-based screening setting? (ERSPC, section Rotterdam).
Roobol MJ; Roobol DW; Schröder FH
Urology; 2005 Feb; 65(2):343-6. PubMed ID: 15708050
[TBL] [Abstract][Full Text] [Related]
13. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
Schröder FH
Can J Urol; 2005 Feb; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
Platz EA; Rohrmann S; Pearson JD; Corrada MM; Watson DJ; De Marzo AM; Landis PK; Metter EJ; Carter HB
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):390-6. PubMed ID: 15734963
[TBL] [Abstract][Full Text] [Related]
15. Population-based study of prostate-specific antigen testing and prostate cancer detection in clinical practice in northern Sweden.
Pilebro B; Johansson R; Damber L; Damber JE; Stattin P
Scand J Urol Nephrol; 2003; 37(3):210-2. PubMed ID: 12775278
[TBL] [Abstract][Full Text] [Related]
16. Trends in prostate cancer incidence and mortality in New Mexico are consistent with an increase in effective screening.
Gilliland F; Becker TM; Smith A; Key CR; Samet JM
Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):105-11. PubMed ID: 8049631
[TBL] [Abstract][Full Text] [Related]
17. Prognostic features in men who died of prostate cancer.
Thompson KE; Hernández J; Canby-Hagino ED; Troyer D; Thompson IM
J Urol; 2005 Aug; 174(2):553-6; discussion 556. PubMed ID: 16006890
[TBL] [Abstract][Full Text] [Related]
18. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
[TBL] [Abstract][Full Text] [Related]
19. Comparison of prostate-specific antigen and hormone levels among men in Singapore and the United States.
Cheng I; Yu MC; Koh WP; Pike MC; Kolonel LN; Henderson BE; Stram DO
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1692-6. PubMed ID: 16030103
[TBL] [Abstract][Full Text] [Related]
20. Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota.
Roberts RO; Bergstralh EJ; Katusic SK; Lieber MM; Jacobsen SJ
J Urol; 1999 Feb; 161(2):529-33. PubMed ID: 9915441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
